Microchip Technology
MCHP
78.02
-3.24
-3.99%
Microchip Technology
US · MCHP
#528 by market cap
Listed 1970
78.02
-3.24
-3.99%
Live - 5344 symbols - heartbeat 125s ago
· 2026-10-08 06:49
Pre-market
76.71
-1.68%
After-hours
78.21
+0.25%
Overnight
77.08
-1.20%
- Market cap
- 42.37B
- P/E (TTM)i
- 114.74
- P/Bi
- 6.57
- EPSi
- 0.22
- Div yieldi
- 2.33%
- 52W posi
- 53%
Reader sentiment
Are you bullish or bearish on MCHP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.23, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.08% YoY
Margins
- Gross margin
- 57.73%
- Operating margin
- 11.24%
- Net margin
- 2.52%
Key ratios & quality
- Enterprise valuei
- 47.66B
- Altman Z-Scorei
- 4.23
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.35B | 5.27B | 5.44B | 6.82B | 8.44B | 7.63B | 4.40B | 4.71B |
| Gross profit | 2.93B | 3.24B | 3.38B | 4.45B | 5.70B | 5.00B | 2.47B | 2.72B |
| Selling & admin expenses | 682.90M | 676.60M | 610.30M | 718.90M | 797.70M | 734.20M | 617.70M | 674.30M |
| Research & development | 826.30M | 877.80M | 836.40M | 989.10M | 1.12B | 1.10B | 983.80M | 1.09B |
| Operating profit | 748.00M | 693.80M | 999.80M | 1.88B | 3.11B | 2.56B | 375.50M | 529.80M |
| Pretax profit | 204.50M | 150.40M | 339.50M | 1.48B | 2.91B | 2.37B | 38.90M | 273.50M |
| Tax | -151.40M | -420.20M | -9.90M | 197.00M | 672.00M | 459.00M | 39.40M | 43.50M |
| Net profit | 355.90M | 570.60M | 349.40M | 1.29B | 2.24B | 1.91B | -500.00K | 230.00M |
| Basic EPS | 1 | 1 | 1 | 2 | 4 | 4 | 0 | 0 |
| Diluted EPS | 0.71 | 1.11 | 0.65 | 2.27 | 4.02 | 3.48 | -0.01 | 0.22 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 970.50M | 1.08B | 1.14B | 1.19B | 1.31B | 1.48B |
| Gross profit | 501.10M | 576.70M | 637.90M | 706.90M | 799.60M | 938.90M |
| Selling & admin expenses | 152.00M | 159.30M | 172.30M | 168.50M | 174.20M | 184.30M |
| Research & development | 255.20M | 255.50M | 262.30M | 274.30M | 293.80M | 308.90M |
| Operating profit | -28.70M | 54.30M | 95.20M | 156.50M | 223.80M | 355.70M |
| Pretax profit | -168.30M | -15.80M | 31.80M | 93.60M | 163.90M | 289.90M |
| Tax | -13.70M | 2.80M | -9.90M | 30.90M | 19.70M | 60.10M |
| Net profit | -154.60M | -18.60M | 41.70M | 62.70M | 144.20M | 229.80M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.29 | -0.09 | 0.03 | 0.06 | 0.21 | 0.37 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.21B | 2.22B | 2.15B | 2.45B | 3.07B | 3.01B | 2.99B | 2.38B |
| Cash & ST investments | 430.90M | 403.00M | 282.00M | 319.40M | 234.00M | 319.70M | 771.70M | 240.30M |
| Inventory | 711.70M | 685.70M | 665.00M | 854.40M | 1.32B | 1.32B | 1.29B | 1.04B |
| Total assets | 18.35B | 17.43B | 16.48B | 16.20B | 16.37B | 15.87B | 15.37B | 14.37B |
| Total current liabilities | 2.37B | 1.64B | 2.41B | 1.40B | 3.12B | 2.52B | 1.16B | 1.14B |
| Short-term debt | 1.36B | 653.30M | 1.36B | 33.80M | 1.43B | 1.03B | 35.70M | 38.80M |
| Long-term debt | 8.95B | 8.87B | 7.58B | 7.69B | 5.04B | 5.00B | 5.63B | 5.50B |
| Total liabilities | 13,062,500,000.00 | 11,840,600,000.00 | 11,141,700,000.00 | 10,304,700,000.00 | 9,856,700,000.00 | 9,215,400,000.00 | 8,296,300,000.00 | 7,937,700,000.00 |
| Total equity | 5.29B | 5.59B | 5.34B | 5.89B | 6.51B | 6.66B | 7.08B | 6.43B |
| Retained earnings | 3.21B | 3.43B | 3.39B | 4.18B | 5.76B | 6.76B | 5.78B | 4.92B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.99B | 2.75B | 2.35B | 2.29B | 2.38B | 2.49B |
| Cash & ST investments | 771.70M | 566.50M | 236.80M | 250.70M | 240.30M | 272.30M |
| Inventory | 1.29B | 1.17B | 1.10B | 1.06B | 1.04B | 1.05B |
| Total assets | 15.37B | 14.98B | 14.47B | 14.33B | 14.37B | 14.41B |
| Total current liabilities | 1.16B | 1.19B | 1.04B | 1.06B | 1.14B | 1.29B |
| Short-term debt | 35.70M | 36.40M | 36.80M | 38.60M | 38.80M | 37.40M |
| Long-term debt | 5.63B | 5.46B | 5.38B | 5.37B | 5.50B | 5.36B |
| Total liabilities | 8,296,300,000.00 | 8,122,400,000.00 | 7,774,200,000.00 | 7,765,100,000.00 | 7,937,700,000.00 | 7,956,400,000.00 |
| Total equity | 7.08B | 6.86B | 6.70B | 6.56B | 6.43B | 6.45B |
| Retained earnings | 5.78B | 5.49B | 5.26B | 5.05B | 4.92B | 4.87B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.67B | 1.54B | 1.92B | 2.84B | 3.62B | 2.89B | 898.10M | 962.10M |
| Depreciation & amortization | 876.40M | 1.22B | 1.15B | 1.14B | 998.40M | 879.50M | 750.10M | 689.30M |
| Free cash flow | 1.45B | 1.48B | 1.82B | 2.47B | 3.13B | 2.61B | 772.10M | 871.00M |
| Dividends paid | -344.40M | -350.10M | -388.30M | -503.80M | -695.30M | -911.50M | -975.70M | -1.09B |
| Stock buybacks / issuance | 42.60M | 58.80M | 60.30M | -355.10M | -863.50M | -900.00M | -31.10M | 61.70M |
| Ending cash balance | 428.60M | 401.00M | 280.00M | 317.40M | 234.00M | 319.70M | 771.70M | 240.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 205.90M | 275.60M | 88.10M | 341.40M | 257.00M | 511.50M |
| Depreciation & amortization | 187.00M | 171.10M | 172.70M | 171.80M | 173.70M | 156.70M |
| Free cash flow | 191.70M | 257.70M | 51.60M | 318.90M | 242.80M | 497.60M |
| Dividends paid | -244.80M | -270.60M | -273.60M | -273.90M | -274.40M | -274.70M |
| Stock buybacks / issuance | 20.00M | 12.40M | 17.90M | 12.20M | 19.20M | 13.00M |
| Ending cash balance | 771.70M | 566.50M | 236.80M | 250.70M | 240.30M | 272.30M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.31 | 10.50 | 6.40 | 22.89 | 36.07 | 28.96 | -0.04 | 1.76 |
| ROA %i | 2.68 | 3.19 | 2.06 | 7.87 | 13.74 | 11.83 | -0.02 | 0.80 |
| ROIC %i | 6.54 | 6.07 | 4.06 | 10.74 | 17.94 | 16.01 | 1.40 | 2.35 |
| 5-year avg ROE %i | 11.06 | 9.62 | 7.81 | 11.18 | 16.83 | 20.96 | 18.85 | 17.93 |
| EBIT margin %i | 13.22 | 12.28 | 12.49 | 25.33 | 36.78 | 33.49 | 6.60 | 10.37 |
| FCF / sales %i | 27.03 | 27.99 | 33.54 | 36.25 | 37.15 | 34.16 | 17.54 | 18.48 |
| Current ratioi | 0.93 | 1.35 | 0.89 | 1.75 | 0.98 | 1.20 | 2.59 | 2.09 |
| Quick ratioi | 0.55 | 0.82 | 0.53 | 0.99 | 0.49 | 0.58 | 1.27 | 1.00 |
| Debt / assetsi | 56.17 | 54.67 | 54.28 | 47.66 | 39.53 | 38.00 | 36.85 | 38.52 |
| LT debt / equityi | 169.20 | 158.86 | 142.05 | 130.41 | 77.40 | 75.11 | 79.54 | 85.45 |
| Interest coveragei | 1.41 | 1.30 | 2.00 | 7.04 | 15.97 | 13.39 | 1.15 | 2.27 |
| Revenue CAGR (3Y) %i | 35.02 | 15.67 | 10.96 | 8.44 | 16.96 | 11.97 | -13.58 | -17.65 |
| Net income CAGR (3Y) %i | 3.17 | 51.34 | 11.01 | 53.43 | 57.70 | 76.06 | -- | -53.16 |
| FCF CAGR (3Y) %i | 30.77 | 14.47 | 14.57 | 19.58 | 28.54 | 12.65 | -32.16 | -34.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -0.04 | -2.69 | -3.75 | -2.45 | 1.76 | 5.52 |
| ROA %i | -0.02 | -1.16 | -1.61 | -1.03 | 0.80 | 2.50 |
| ROIC %i | 1.40 | -0.02 | -0.21 | 0.08 | 2.35 | 4.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.60 | 2.57 | 1.13 | 4.00 | 10.37 | 15.33 |
| FCF / sales %i | 17.54 | 17.13 | 17.91 | 18.75 | 18.48 | 21.69 |
| Current ratioi | 2.59 | 2.31 | 2.25 | 2.16 | 2.09 | 1.92 |
| Quick ratioi | 1.27 | 1.12 | 0.94 | 0.93 | 1.00 | 0.96 |
| Debt / assetsi | 36.85 | 36.68 | 37.41 | 37.73 | 38.52 | 37.47 |
| LT debt / equityi | 79.54 | 79.60 | 80.29 | 81.79 | 85.45 | 83.11 |
| Interest coveragei | 1.15 | 0.44 | 0.19 | 0.75 | 2.27 | 3.81 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Semiconductor Products is the largest reported line at 97.13% of revenue, across 2 reported segments.
- The next-largest line, Technology Licensing, is a distant second at 2.87% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Semiconductor Products97.13%
Technology Licensing2.87%
Quote time 2026-10-08 06:49:16 · For reference only, not investment advice and not tailored to your situation.